interstate,
The prolonged discussion with Rabin last night was strictly on the topic of prior post...numbers only
CC,
I thought the CC was fine and should have been helpful to many. As stated prior I think CC's are a good thing and I am glad it will continue. While there wasn't earth shattering news(wasn't expecting any) I did learn a few things that I hadn't known which is always good. Davpar posted much of the highlights. The "books" are at the point of being cleansed and as stated in CC the only thing holding ACT back from the big boards is pps, which we pretty much knew. All the effort and expense to "cleanse" was NOT to stay on OTC..:) Sustaining any pps increases has been a major problem here for 5 years. I am hoping with the start of trials that will change, at least enough so if a reverse is used it will be smaller than what it would take now. When I see ACT data on clinicaltrials.gov, I will know we are positioned to see what the MA-09hRPE can do.